Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Event Calendar
Subscribe

|Articles|May 9, 2019

Managing Your Site Selection at the Portfolio Level

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: FDA Issues CRL to Elevar Therapeutics

ByNicholas Jacobus

July 13th 2026

David Hung

Nuvation Bio’s Approach to Building a Compelling Narrative

ByMike Hollan,David Hung

July 13th 2026

stock.adobe.com Collaboration

Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration

ByNicholas Jacobus

July 13th 2026

Stock.Adobe.com Complete response letter

FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab

ByNicholas Jacobus

July 13th 2026

stock.adobe.com DTC

DTP is Scaling Fast, the Safety Infrastructure is Not

ByJames Cleffi ,Sierra Benbrook ,Megan Shea

July 13th 2026

Trending on PharmExec

DTP is Scaling Fast, the Safety Infrastructure is Not

U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels

Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration

AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial

FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab